Theravance Biopharma (TBPH) Other Operating Expenses (2014 - 2026)

Theravance Biopharma (TBPH) has 11 years of Other Operating Expenses data on file, last reported at $1.0 million in Q1 2026.

• On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $1.0 million in Q1 2026; TTM through Mar 2026 was $1.0 million, a 77.24% decrease from a year earlier, with the FY2024 full-year figure at $4.5 million, changed N/A from the prior year.
• Other Operating Expenses for Q1 2026 stood at $1.0 million, up from -$1000.0 in the prior quarter.
• Over the last five years, Other Operating Expenses for TBPH reached as high as $3.0 million in Q2 2024 and fell as low as -$37.5 million in Q3 2022.
• Historically, Other Operating Expenses has averaged -$7.4 million across 4 years, with a median of $19000.0 in 2022.
• On a YoY basis, Other Operating Expenses climbed as much as 7.14% in 2022 and fell as far as 175.51% in 2022.
• Year by year, Other Operating Expenses stood at $39000.0 in 2022, then surged by 3905.13% to $1.6 million in 2024, then slumped by 100.06% to -$1000.0 in 2025, then surged by 102900.0% to $1.0 million in 2026.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $1.0 million in Q1 2026, -$1000.0 in Q4 2025, and $1.6 million in Q3 2024.